UNHUNHHealthcare · Healthcare Plans

UNH Stock Forecast: UnitedHealth Group, Inc. Price Predictions for 2026-2027

Last close, 14 Oct 2026
$396
+4.73% on the day

The 26 Wall Street analysts covering UnitedHealth Group, Inc. hold a median 12-month price target of $490 — +23.9% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 78 of 100 as at 14 Oct 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$355.1B
Ticker Nerd rank
78 / 100
Median analyst target
$490
Analysts covering
26
Revenue$112.0B+0.4% y/y
Operating income$8.0B
Net income$5.7B
Free cash flow$10.3B
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+5.2%
1M
+3.1%
YTD
+22.2%
1Y
+12.8%
From 52W high
−8.8%
From 52W low
+54.5%
$256
$434
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

UNH stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores UnitedHealth Group, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 14 Oct 2026
78 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Revisions
91
Issuance
90
Volatility
89
Value
83
Momentum
66
Accruals
51
Growth
49
Quality
45
Size
1

Revisions (91): Analysts have, on balance, been raising their forecasts.

Quality (45): Profits are thin or unreliable for the size of the business, or they are not turning into cash.

Size (1): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

UNH stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on UNH, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$200$300$400$500$600Jan 26Apr 26Jul 26Oct 26UNHHigh $529Median $490Low $380

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says26 analysts
22 Buy4 Hold0 Sell
Low $380Median $490High $529

The green dot is the last close — the median target sits +23.9% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 10 moved their price target up and 1 moved it down.

DateFirmActionRatingTarget
9 Oct 2026TD CowenMaintainsHold$430 → $402
21 July 2026JP MorganMaintainsOverweight—
21 July 2026JP MorganMaintainsOverweight$466 → $516
21 July 2026MizuhoMaintainsOutperform—
21 July 2026MizuhoMaintainsOutperform$470 → $493
20 July 2026BarclaysMaintainsOverweight$429 → $441
20 July 2026BarclaysMaintainsOverweight—
17 July 2026KeybancMaintainsOverweight—
17 July 2026KeybancMaintainsOverweight$475 → $500
17 July 2026Morgan StanleyMaintainsOverweight$468 → $529
17 July 2026Morgan StanleyMaintainsOverweight—
17 July 2026OppenheimerMaintainsOutperform—
17 July 2026OppenheimerMaintainsOutperform$420 → $500
17 July 2026RBC CapitalMaintainsOutperform$463 → $478
17 July 2026RBC CapitalMaintainsOutperform—
17 July 2026Truist SecuritiesMaintainsBuy$480 → $500
17 July 2026Truist SecuritiesMaintainsBuy—
17 July 2026UBSMaintainsBuy$460 → $490
17 July 2026UBSMaintainsBuy—
16 July 2026BairdUpgradeNeutral$287 → $453

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. UNH appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

UNH vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 14 Oct 2026, UnitedHealth Group, Inc. returned +12.8% against +17.5% for the S&P 500, dividends included.

UNH vs S&P 500, last 12 monthsTotal return, rebased to 100
708090100110120Jan 26Apr 26Jul 26Oct 26UNHS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

UNH analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+7.9%
Analysts raising
2
Analysts cutting
0
Fundamentals

UnitedHealth Group, Inc. (UNH) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
25.4×

Cheaper than 30% of US stocks

Price / sales
0.8×

Cheaper than 73% of US stocks

Price / book
3.4×

Cheaper than 27% of US stocks

EV / EBITDA
13.4×

Cheaper than 26% of US stocks

Growth & margins
Revenue growth (YoY)
−0.4%

Higher than 27% of US stocks

Earnings growth (YoY)
75.0%

Higher than 80% of US stocks

Gross margin
20.8%

Higher than 22% of US stocks

Operating margin
5.8%

Higher than 57% of US stocks

Net margin
3.5%

Higher than 56% of US stocks

Returns & dividend
Return on equity
15.8%

Higher than 75% of US stocks

Return on assets
5.2%

Higher than 78% of US stocks

Dividend yield
2.3%

Higher than 81% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

UnitedHealth Group, Inc. (UNH) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • UnitedHealth Group, Inc. has a market value of $355.1B and an enterprise value of $387.9B.

  • Revenue in the twelve months to 30 June 2026: $450.1B. The latest quarter shrank 0.4% year on year.

  • Net income over the same four quarters: $14.9B, a 3.3% net margin.

  • Diluted earnings per share, trailing twelve months: $15.54.

  • Free cash flow in the twelve months to 30 June 2026: $23.6B.

  • UnitedHealth Group, Inc. spent $1.6B on share buybacks and $8.1B on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 905.0M.

  • Trailing P/E: 25.4×; forward P/E: 17.1× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 2.34%, paying out 58% of earnings.

  • UnitedHealth Group, Inc. employs 390,000 people — $1.2M of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 15 Oct 2026

Data provided by Twelve Data

Peers

UNH vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealthcare Plans
CompanyMarket capTKN rank
UNHUnitedHealth Group, Inc.$355.1B
78
CVSCVS Health Corp.$114.7B
86
ELVElevance Health, Inc.$95.1B
73
CIThe Cigna Group$76.5B
75
HUMHumana, Inc.$51.4B
48
CNCCentene Corp.$34.5B
93
MRKMerck & Co., Inc.*$365.8B
81

* Nearest Healthcare names by size — few healthcare plans companies of this scale trade in the US universe.

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own UnitedHealth Group, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest UNH news & analysis

UnitedHealth Is Earning More From Less

Seeking Alpha · 14 Oct 2026positive

UnitedHealth reported Q3 adjusted EPS of $4.69, up 61%, and raised its 2026 adjusted EPS outlook to at least $20.50. Its medical care ratio improved to 88.4%, with about 70 basis points of the improvement from favorable reserve development; nine-month operating cash flow was $25.1 billion.

Why it matters — The earnings, outlook, medical care ratio, and cash flow provide UNH watchers several measures of the company’s financial performance, including the contribution of reserve development.

UnitedHealth is Down Big Over 3 Months: A Big Bank Says 40% Gains to Come After Raising Their Target

24/7 Wall Street · 14 Oct 2026neutral

UnitedHealth has shed members and slipped 10% over three months, closing lower despite a quarter that beat expectations and included raised guidance. The headline reports that a big bank raised its target and sees potential for 40% gains.

Why it matters — The combination of membership losses and recent share-price weakness, alongside stronger quarterly results and an increased bank target, gives UNH watchers contrasting developments to consider.

UnitedHealth Stock Moves Higher: What's Happening?

Benzinga · 14 Oct 2026positive

UnitedHealth Group shares climbed Wednesday after Bernstein reiterated its rating and price target following the company’s third-quarter earnings beat.

Why it matters — The update links the share move to Bernstein’s reiterated view and the recent earnings result, both relevant to UNH watchers.

UNH Q3 Earnings Call Highlights 2027 Growth and Margin Recovery

Zacks Investment Research · 14 Oct 2026positive

UnitedHealth raised its 2026 earnings outlook and outlined a target for stronger growth in 2027. Commercial medical costs and Medicaid pressures continue to challenge margin recovery.

Why it matters — The outlook and cost pressures provide context on UnitedHealth’s growth plans and the challenges to restoring margins.

UnitedHealth Group (UNH) is a Top-Ranked Momentum Stock: Should You Buy?

Zacks Investment Research · 14 Oct 2026positive

Zacks Investment Research highlights UnitedHealth Group (UNH) as a top-ranked momentum stock. The excerpt points to Zacks Style Scores, a feature of its Zacks Premium research service, as a tool for finding stocks across investing styles.

Why it matters — UNH watchers may note the favorable momentum ranking and the research feature behind it.

FAQ

Frequently asked questions about UNH stock

What is the UNH stock price forecast for 2026-2027?

The 26 Wall Street analysts covering UnitedHealth Group, Inc. have a median 12-month price target of $490, with estimates ranging from $380 to $529. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is UNH stock a buy right now?

Of the 26 analysts covering UnitedHealth Group, Inc., 22 rate it a Buy, 4 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks UnitedHealth Group, Inc. 78 out of 100 across roughly 4,600 US stocks as at 14 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank UNH?

As at 14 Oct 2026, UnitedHealth Group, Inc. ranks 78 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (91 of 100).

Will UNH stock go up?

No one can know that. What the data says: the median 12-month target from 26 analysts implies +23.9% from the last close, and Ticker Nerd's factor model ranks UnitedHealth Group, Inc. 78 out of 100 as at 14 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the UNH stock forecast for 2030?

No analyst covering UnitedHealth Group, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for UNH are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $380 to $529 over the next 12 months.

How has UNH stock performed over the past year?

UnitedHealth Group, Inc. returned +12.8% over the 12 months to 14 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does UnitedHealth Group, Inc. do?

UnitedHealth Group Inc. is a healthcare and well-being company that operates through two core businesses, UnitedHealthcare and Optum.

What is the latest news on UNH?

The most recent item we track (Seeking Alpha, 14 Oct 2026): "UnitedHealth Is Earning More From Less". UnitedHealth reported Q3 adjusted EPS of $4.69, up 61%, and raised its 2026 adjusted EPS outlook to at least $20.50. Its medical care ratio improved to 88.4%, with about 70 basis points of the improvement from favorable reserve development; nine-month operating cash flow was $25.1 billion.

Company

About UnitedHealth Group, Inc.

UnitedHealth Group Inc. is a healthcare and well-being company that operates through two core businesses, UnitedHealthcare and Optum. UnitedHealthcare provides a broad range of health benefit plans and services for employers, individuals, government programs, and public-sector clients, while Optum delivers care delivery, pharmacy care services, health information technology, data analytics, consulting, and managed services. Together, these businesses support patients, care providers, employers, and governments across the health system. UnitedHealth Group plays a central role in health insurance, care coordination, and healthcare services, with a focus on improving access to care, simplifying the consumer experience, and supporting more efficient health system operations. Headquartered in Eden Prairie, Minnesota, and founded in 1974, UnitedHealth Group is one of the most important companies in the healthcare market.

CEO Mr. Stephen J. Hemsley · 390,000 employees · United States · https://www.unitedhealthgroup.com